{
    "Trade/Device Name(s)": [
        "OPTI\u00ae B-Lac Cassette"
    ],
    "Submitter Information": "OPTI Medical Systems, Inc.",
    "510(k) Number": "K200986",
    "Predicate Device Reference 510(k) Number(s)": [
        "K092686",
        "K131126"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CHL",
        "GKR",
        "GLY"
    ],
    "Summary Letter Date": "March 3, 2021",
    "Summary Letter Received Date": "March 4, 2021",
    "Submission Date": "April 6, 2020",
    "Regulation Number(s)": [
        "21 CFR 862.1120",
        "21 CFR 864.5620",
        "21 CFR 864.7500",
        "21 CFR 862.1450"
    ],
    "Regulation Name(s)": [
        "Blood Gases (pCO2, pO2) And Blood pH Test System",
        "Automated hemoglobin test system",
        "Whole blood hemoglobin test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "hematology"
    ],
    "Analyte(s)": [
        "pH",
        "PO2",
        "PCO2",
        "Total hemoglobin (tHb)",
        "Oxygen saturation (SO2)"
    ],
    "Specimen Type(s)": [
        "Whole blood (sodium heparinized, venous)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "OPTI CCA-TS",
        "OPTI CCA-TS2"
    ],
    "Method(s)/Technology(ies)": [
        "Fluorescence optodes",
        "Optical reflectance measurement"
    ],
    "Methodologies": [
        "In vitro quantitative measurement"
    ],
    "Submission Type(s)": [
        "Cassette",
        "Reagent",
        "Component"
    ],
    "Document Summary": "FDA 510(k) summary for OPTI\u00ae B-Lac Cassette for in vitro measurement of blood gases, pH, total hemoglobin, and oxygen saturation on OPTI CCA-TS/TS2 platforms",
    "Indications for Use Summary": "Intended for in vitro measurement of pH, PO2, PCO2, total hemoglobin (tHb), and percent oxygen saturation (SO2) in sodium heparinized venous blood samples on the OPTI CCA-TS and OPTI CCA-TS2 platforms in a clinical laboratory.",
    "fda_folder": "Clinical Chemistry"
}